Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • Latest News

    Latest News - Page 338

    India fast emerging as inventors hub for drugs patent

    India fast emerging as inventors hub for drugs patent

    Ruby Khatun Khatun25 Dec 2017 10:30 AM IST
    Chandigarh: India is fast emerging as an inventors' hub for patents for an assortment of drugs worldwide. Around 15 percent of the total 1.3 lakh...
    FDA clears stereotactic radiotherapy system for use in treating breast cancer

    FDA clears stereotactic radiotherapy system for use in treating breast cancer

    Ruby Khatun Khatun25 Dec 2017 10:18 AM IST
    The U.S. Food and Drug Administration (FDA) cleared a new noninvasive stereotactic radiotherapy system intended for use in treating cancer in breast...
    Roche scores cancer drug approvals in Europe and US

    Roche scores cancer drug approvals in Europe and US

    Ruby Khatun Khatun25 Dec 2017 10:15 AM IST
    ZURICH: Swiss drugmaker Roche has won fresh approvals for two cancer drugs in Europe and the United States, shoring up its position in new medicines...
    US judge tosses verdict against AbbVie in AndroGel case

    US judge tosses verdict against AbbVie in AndroGel case

    Ruby Khatun Khatun25 Dec 2017 10:00 AM IST
    A U.S. judge on Friday overturned a $150 million verdict against AbbVie Inc that was the first to result from lawsuits claiming that the company...
    United Therapeutics to pay 210 million dollars to resolve US kickback probe

    United Therapeutics to pay 210 million dollars to resolve US kickback probe

    Ruby Khatun Khatun25 Dec 2017 9:45 AM IST
    BOSTON: United Therapeutics Corp will pay $210 million to resolve U.S. claims that the drugmaker used a charity as a conduit to illegally cover...
    California court says Novartis can be sued over generic drug injuries

    California court says Novartis can be sued over generic drug injuries

    Ruby Khatun Khatun25 Dec 2017 9:30 AM IST
    California’s top court opened the door for consumers to sue Novartis AG and other makers of brand-name pharmaceutical products over injuries blamed on...
    Roche to buy US cancer drugmaker Ignyta for 1.7 billion dollars

    Roche to buy US cancer drugmaker Ignyta for 1.7 billion dollars

    Ruby Khatun Khatun24 Dec 2017 10:30 AM IST
    Swiss drugmaker Roche will buy U.S. cancer drug specialist Ignyta Inc for $1.7 billion in an agreed deal to broaden its oncology portfolio, the firms...
    USFDA approves new diabetes drug from Merck and Pfizer

    USFDA approves new diabetes drug from Merck and Pfizer

    Ruby Khatun Khatun24 Dec 2017 10:15 AM IST
    A new drug developed by Merck & Co and Pfizer Inc won U.S. approval to treat type II diabetes, the Food and Drug Administration said, adding...
    Dr Agarwals Eye Hospital launches Karnatakas first and only refractive hub

    Dr Agarwal's Eye Hospital launches Karnataka's first and only refractive hub

    Ruby Khatun Khatun24 Dec 2017 10:00 AM IST
    BENGALURU: Dr. Agarwal's Eye Hospital, a comprehensive eye hospital offering a complete solution for eye ailments launched Karnataka's first and only...
    Review graphical health warning rules on tobacco items: FAIFA

    Review graphical health warning rules on tobacco items: FAIFA

    Ruby Khatun Khatun24 Dec 2017 9:45 AM IST
    New Delhi: Farmers’ body FAIFA asked the government to review current rules on graphical health warnings on tobacco products, saying it is hurting all...
    Samsung Bioepis says FDA to review Herceptin copy

    Samsung Bioepis says FDA to review Herceptin copy

    Ruby Khatun Khatun24 Dec 2017 9:30 AM IST
    SEOUL: South Korea’s Samsung Bioepis Co Ltd said on Wednesday the U.S. Food and Drug Administration (FDA) has accepted for review its copy of Swiss...
    Carlyle Group acquires majority stake in Visionary RCM

    Carlyle Group acquires majority stake in Visionary RCM

    Ruby Khatun Khatun23 Dec 2017 10:45 AM IST
    MUMBAI: Global alternative asset manager, Carlyle Group, on Thursday said it has acquired the majority stake in Visionary RCM Infotech (India) to...
    PrevNext

    Popular Stories

    FDC Ban: Supreme Court Relief to Saridon, Piriton and Dart

    FDC Ban: Supreme Court Relief to Saridon, Piriton and Dart

    Ayurvedic Medicines for Blood Sugar, Diet containing Metformin Hydrochloride: Ayurveda Firm Booked

    Ayurvedic Medicines for Blood Sugar, Diet containing Metformin Hydrochloride: Ayurveda Firm Booked

    Rising prices of hydroxychloroquine raw material forces small scale pharmas in Haridwar to stop production

    Rising prices of hydroxychloroquine raw material forces small scale pharmas in Haridwar to stop...

    Owner of BLK Hospital, Radiant Life care looks to buy Max Healthcare stake

    Owner of BLK Hospital, Radiant Life care looks to buy Max Healthcare stake

    Union Pharma Secretary Holds video conference with Pharma manufacturers and associations, takes feedback

    Union Pharma Secretary Holds video conference with Pharma manufacturers and associations, takes...

    Illegal steroid smuggling ring allegedly led by India-based Alpha Pharma busted in UK

    Illegal steroid smuggling ring allegedly led by India-based Alpha Pharma busted in UK

    French court dismisses damage claims against Merck over Levothyrox

    French court dismisses damage claims against Merck over Levothyrox

    Novartis Expiry of Patent for Blockbuster Vildagliptin to Clear Way for Competitors

    Novartis Expiry of Patent for Blockbuster Vildagliptin to Clear Way for Competitors

    View All

    • Email: info@medicaldialogues.in
    • Phone: 011 - 4372 0751

    Website Last Updated On : 13 Oct 2022 5:14 AM GMT
    Company
    • About Us
    • Contact Us
    • Our Team
    • Reach our Editor
    • Feedback
    • Submit Article
    Ads & Legal
    • Advertise
    • Advertise Policy
    • Terms and Conditions
    • Privacy Policy
    • Editorial Policy
    • Comments Policy
    • Disclamier
    Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

    Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

    © 2025 - Medical Dialogues. All Rights Reserved.
    Powered By: Hocalwire
    X
    We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok